These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 16372532)
1. Expression profile of copper transporters in sensitive and cisplatin/oxaliplatin-resistant tumor cell lines. Kassack MU; Stratenschulte C Int J Clin Pharmacol Ther; 2005 Dec; 43(12):597-8. PubMed ID: 16372532 [No Abstract] [Full Text] [Related]
2. Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells. Plasencia C; Martínez-Balibrea E; Martinez-Cardús A; Quinn DI; Abad A; Neamati N Int J Oncol; 2006 Jul; 29(1):225-35. PubMed ID: 16773204 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Samimi G; Safaei R; Katano K; Holzer AK; Rochdi M; Tomioka M; Goodman M; Howell SB Clin Cancer Res; 2004 Jul; 10(14):4661-9. PubMed ID: 15269138 [TBL] [Abstract][Full Text] [Related]
4. Role of copper transporters in resistance to platinating agents. Rabik CA; Maryon EB; Kasza K; Shafer JT; Bartnik CM; Dolan ME Cancer Chemother Pharmacol; 2009 Jun; 64(1):133-42. PubMed ID: 18998134 [TBL] [Abstract][Full Text] [Related]
5. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines. Kitada N; Takara K; Minegaki T; Itoh C; Tsujimoto M; Sakaeda T; Yokoyama T Cancer Chemother Pharmacol; 2008 Sep; 62(4):577-84. PubMed ID: 18030470 [TBL] [Abstract][Full Text] [Related]
6. Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B. Samimi G; Katano K; Holzer AK; Safaei R; Howell SB Mol Pharmacol; 2004 Jul; 66(1):25-32. PubMed ID: 15213293 [TBL] [Abstract][Full Text] [Related]
7. Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC). Li ZH; Qiu MZ; Zeng ZL; Luo HY; Wu WJ; Wang F; Wang ZQ; Zhang DS; Li YH; Xu RH J Transl Med; 2012 Feb; 10():21. PubMed ID: 22304828 [TBL] [Abstract][Full Text] [Related]
8. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines. Yoshizawa K; Nozaki S; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E Oncol Rep; 2007 Oct; 18(4):987-91. PubMed ID: 17786364 [TBL] [Abstract][Full Text] [Related]
9. Copper transporter 1 in human colorectal cancer cell lines: Effects of endogenous and modified expression on oxaliplatin cytotoxicity. Cui H; Zhang AJ; McKeage MJ; Nott LM; Geraghty D; Guven N; Liu JJ J Inorg Biochem; 2017 Dec; 177():249-258. PubMed ID: 28551160 [TBL] [Abstract][Full Text] [Related]
10. Sec61β controls sensitivity to platinum-containing chemotherapeutic agents through modulation of the copper-transporting ATPase ATP7A. Abada PB; Larson CA; Manorek G; Adams P; Howell SB Mol Pharmacol; 2012 Sep; 82(3):510-20. PubMed ID: 22710939 [TBL] [Abstract][Full Text] [Related]
11. Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug. Leonhardt K; Gebhardt R; Mössner J; Lutsenko S; Huster D J Biol Chem; 2009 Mar; 284(12):7793-802. PubMed ID: 19141620 [TBL] [Abstract][Full Text] [Related]
12. Dual role of LRRC8A-containing transporters on cisplatin resistance in human ovarian cancer cells. Sørensen BH; Dam CS; Stürup S; Lambert IH J Inorg Biochem; 2016 Jul; 160():287-95. PubMed ID: 27112899 [TBL] [Abstract][Full Text] [Related]
13. Translocation of platinum anticancer drugs by human copper ATPases ATP7A and ATP7B. Tadini-Buoninsegni F; Bartolommei G; Moncelli MR; Inesi G; Galliani A; Sinisi M; Losacco M; Natile G; Arnesano F Angew Chem Int Ed Engl; 2014 Jan; 53(5):1297-301. PubMed ID: 24375922 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B. Dmitriev OY Biochem Cell Biol; 2011 Apr; 89(2):138-47. PubMed ID: 21455266 [TBL] [Abstract][Full Text] [Related]
15. miR-133a enhances the sensitivity of Hep-2 cells and vincristine-resistant Hep-2v cells to cisplatin by downregulating ATP7B expression. Wang X; Zhu W; Zhao X; Wang P Int J Mol Med; 2016 Jun; 37(6):1636-42. PubMed ID: 27121102 [TBL] [Abstract][Full Text] [Related]
16. Differences in the cellular response and signaling pathways of cisplatin and BBR3464 ([[trans-PtCl(NH3)(2)]2mu-(trans-Pt(NH3)(2)(H2N(CH2)(6)-NH2)2)]4+) influenced by copper homeostasis. Kabolizadeh P; Ryan J; Farrell N Biochem Pharmacol; 2007 May; 73(9):1270-9. PubMed ID: 17234160 [TBL] [Abstract][Full Text] [Related]
17. The roles of copper transporters in cisplatin resistance. Kuo MT; Chen HH; Song IS; Savaraj N; Ishikawa T Cancer Metastasis Rev; 2007 Mar; 26(1):71-83. PubMed ID: 17318448 [TBL] [Abstract][Full Text] [Related]
18. Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells. Doherty B; Lawlor D; Gillet JP; Gottesman M; O'Leary JJ; Stordal B Anticancer Res; 2014 Jan; 34(1):503-7. PubMed ID: 24403508 [TBL] [Abstract][Full Text] [Related]
19. Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Komatsu M; Sumizawa T; Mutoh M; Chen ZS; Terada K; Furukawa T; Yang XL; Gao H; Miura N; Sugiyama T; Akiyama S Cancer Res; 2000 Mar; 60(5):1312-6. PubMed ID: 10728692 [TBL] [Abstract][Full Text] [Related]
20. Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells. Beretta GL; Gatti L; Tinelli S; Corna E; Colangelo D; Zunino F; Perego P Biochem Pharmacol; 2004 Jul; 68(2):283-91. PubMed ID: 15194000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]